维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Golderer G"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	First to Market, First to Fail? Real Causes of Enduring Market Leadership 显示文摘	Tellis G J Golder P N	1996	Sloan Management Review1996，37，：	1
2	Pioneer advantage: marketing logic and marketing legend?显示文摘	Golder P N Tellis G L	1993	Journal of Marketing Research1993，30，：	1
3	Tetrahydrobiop- terin biosynthesis, utilization and pharmacological effects显示文摘	Werner-Felmayer G Golderer G Werner ER	2002	Curt Drug Metab2002，3，2：	1
4	Identification of the gene encoding alkylglycerol monooxygenase defines a third class of tetrahydrobiopterin-dependent enzymes 显示文摘	Watschinger K Keller MA Golderer G	2010	Proc Natl Acad Sci USA2010，107，13：	1
5	First to market, first to fail? real causes of enduring market Leadership 显示文摘	Tellis G J Golder P N	1996	Sloan Management Review1996，37，2：	1
6	Low densitylipoprotein binds to proprotein convertase subtilisin/kexintype-9 (PCSK9) in human plasma and inhibits PCSK9-mediatedlow density lipoprotein receptor degradation显示文摘	Kosenko T Golder M Leblond G	2013	J Biol Chem2013，288，12：	1
7	Tetrahydrobiopterin biosynthesis,utilization and pharmacological effects显示文摘	Werner-Felmayer G Golderer G Werner ER	2002	Current Drug Metabolism2002，3，：	1
8	Low density lipoproteinbinds to proprotein convertase subtilisin/kexin type-9(PCSK9) in human plasma and inhibits PCSK9- mediated low density lipoprotein re-ceptor degradation显示文摘	Kosenko T Golder M Leblond G	2013	J Biol Chem2013，288，12：	1
9	Low density lipoprotein binds to proprotein convertase subtilisin/kexin type-9 ( PCSK9 ) in hu- man plasma and inhibits PCSK9-mediated low density lipoprotein re- ceptor degradation显示文摘	Kosenko T Golder M Leblond G	2013	J Biol Chem2013，288，12：	1
10	The amounts of alpha 1 antitrypsin protein are reduced in the vascular wall of the acutely dissected human ascending aorta 显示文摘	Schachner T Golderer G Sarg B	2010	Eur J Cardiothorac Surg2010，37，3：	1
11	Tetrahydrobiopterin biosynthesis,utilization and pharmacological effects显示文摘	Werner-Felmayer G Golderer G Werner ER	2002	Curr Drug Metab2002，3，：	1
12	Polymorphism in vitamin D- binding protein as a genetic risk factor in the pathogenesis of endo- metriosis 显示文摘	Faserl K Golderer G Kremser L	2011	J Clin Endocrinol Metab2011，96，1：	1
13	Beyond Diffusion: An Affordability Model for the Growth of Consumer Durables 显示文摘	Golder P N Tellis G J	1998	Journal of Forecasting1998，17，：	1
14	Tetrahydrobiopterin biosynthesis,utilization and pharmacological effects显示文摘	Werner -Felmayer G Golderer G Werner E R	2002	Curr Drug Metab2002，3，2：	1
15	Low density lipoprotein binds to proprotein convertase subtilisinlkexin type-9 (PCSK9) in human plasma and inhibits PCSK9-mediated low density lipoprotein receptor degradation 显示文摘	Kosenko T Golder M Leblond G	2013	J BioI Chern2013，288，12：	1
16	Low density proprotein convertase subtilisin/kexin type-9(PCSK9)in human plasma and inhibits PCSK9-mediated low density lipoprotein receptor degradation显示文摘	Kosenko T Golder lipoprotein binds to M Leblond G	2013	J Biol Chem2013，288，12：	1
17	Pioneering Advantage: Marketing Fact or Marketing Legend显示文摘	GOLDER P TELLIS G J	1993	Journal of Marketing Research1993，30，2：	1
18	Beyond Diffusion:An Affordability Model of the Growth of New Consumer Durables显示文摘	TELLIS G J	1998	Journal of Forecasting1998，17，3：	1
19	Will It Ever Fly?Modeling the Takeoff of Really New Consumer Durables显示文摘	GOLDER P N TELLIS G J	1997	Marketing Science1997，16，3：	1
20	Polymorphism in vitamin D-binding protein as a genetic risk factor in the pathogenesis of endo- metriosis显示文摘	Faserl K Golderer G Kremser L	2011	J Clin Endocrinol Metab2011，96，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示